Michael D. Hack

2.0k total citations
39 papers, 1.7k citations indexed

About

Michael D. Hack is a scholar working on Molecular Biology, Atomic and Molecular Physics, and Optics and Oncology. According to data from OpenAlex, Michael D. Hack has authored 39 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 13 papers in Atomic and Molecular Physics, and Optics and 5 papers in Oncology. Recurrent topics in Michael D. Hack's work include Advanced Chemical Physics Studies (13 papers), Spectroscopy and Quantum Chemical Studies (11 papers) and Quantum, superfluid, helium dynamics (8 papers). Michael D. Hack is often cited by papers focused on Advanced Chemical Physics Studies (13 papers), Spectroscopy and Quantum Chemical Studies (11 papers) and Quantum, superfluid, helium dynamics (8 papers). Michael D. Hack collaborates with scholars based in United States, Australia and Belgium. Michael D. Hack's co-authors include Donald G. Truhlar, Ahren W. Jasper, Yuri L. Volobuev, David W. Schwenke, Maria S. Topaler, M. Ben-Nun, Todd J. Martı́nez, Piotr Piecuch, Taraneh Mirzadegan and J. Guy Breitenbucher and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Chemical Physics and Journal of The Electrochemical Society.

In The Last Decade

Michael D. Hack

39 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael D. Hack United States	24	954	320	227	207	181	39	1.7k
Dominic A. Zichi United States	18	605 0.6×	536 1.7×	118 0.5×	154 0.7×	285 1.6×	24	1.2k
Rui Sun United States	21	718 0.8×	279 0.9×	423 1.9×	263 1.3×	99 0.5×	106	1.5k
Victor B. Luzhkov Russia	22	477 0.5×	1.4k 4.2×	305 1.3×	429 2.1×	297 1.6×	64	2.3k
Pablo G. Jambrina Spain	23	972 1.0×	228 0.7×	586 2.6×	155 0.7×	53 0.3×	96	1.4k
Christopher Barden Canada	13	292 0.3×	154 0.5×	77 0.3×	269 1.3×	94 0.5×	29	894
Valentine J. Klimkowski United States	22	511 0.5×	590 1.8×	600 2.6×	287 1.4×	347 1.9×	58	1.5k
Tomasz Janowski United States	17	890 0.9×	156 0.5×	311 1.4×	312 1.5×	377 2.1×	32	1.5k
Yuji Takaoka Japan	13	472 0.5×	747 2.3×	118 0.5×	120 0.6×	62 0.3×	21	1.1k
Bogdan Lesyng Poland	25	613 0.6×	827 2.6×	216 1.0×	258 1.2×	331 1.8×	91	1.7k
Ignacio Soteras Spain	17	270 0.3×	501 1.6×	119 0.5×	286 1.4×	254 1.4×	26	1.0k

Countries citing papers authored by Michael D. Hack

Since Specialization

Citations

This map shows the geographic impact of Michael D. Hack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael D. Hack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael D. Hack more than expected).

Fields of papers citing papers by Michael D. Hack

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael D. Hack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael D. Hack. The network helps show where Michael D. Hack may publish in the future.

Co-authorship network of co-authors of Michael D. Hack

This figure shows the co-authorship network connecting the top 25 collaborators of Michael D. Hack. A scholar is included among the top collaborators of Michael D. Hack based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael D. Hack. Michael D. Hack is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ohadi, Donya, Kiran Kumar, Renée L. DesJarlais, et al.. (2024). Input Pose is Key to Performance of Free Energy Perturbation: Benchmarking with Monoacylglycerol Lipase. Journal of Chemical Information and Modeling. 64(23). 8859–8869. 2 indexed citations

Coe, Kevin J., Mark Feinstein, J. William Higgins, et al.. (2022). Characterization of JNJ-2482272 [4-(4-Methyl-2-(4-(Trifluoromethyl)Phenyl)Thiazole-5-yl) Pyrimidine-2-Amine] As a Strong Aryl Hydrocarbon Receptor Activator in Rat and Human. Drug Metabolism and Disposition. 50(8). 1064–1076. 2 indexed citations

Shih, Amy Y., Michael D. Hack, & Taraneh Mirzadegan. (2020). Impact of Protein Preparation on Resulting Accuracy of FEP Calculations. Journal of Chemical Information and Modeling. 60(11). 5287–5289. 15 indexed citations

Blevitt, Jonathan M., Michael D. Hack, Krystal Herman, et al.. (2016). A Single Amino Acid Difference between Mouse and Human 5-Lipoxygenase Activating Protein (FLAP) Explains the Speciation and Differential Pharmacology of Novel FLAP Inhibitors. Journal of Biological Chemistry. 291(24). 12724–12731. 12 indexed citations

Savall, Brad M., Jennifer D. Venable, Jianmei Wei, et al.. (2014). The effect of pKa on pyrimidine/pyridine-derived histamine H4 ligands. Bioorganic & Medicinal Chemistry Letters. 24(23). 5489–5492. 2 indexed citations

Tran, Da‐Thao, Pascal Bonaventure, Michael D. Hack, et al.. (2011). Chimeric, mutant orexin receptors show key interactions between orexin receptors, peptides and antagonists. European Journal of Pharmacology. 667(1-3). 120–128. 25 indexed citations

Hawryluk, Natalie A., Alec D. Lebsack, Michael D. Hack, et al.. (2010). Discovery and synthesis of 6,7,8,9-tetrahydro-5H-pyrimido-[4,5-d]azepines as novel TRPV1 antagonists. Bioorganic & Medicinal Chemistry Letters. 20(23). 7137–7141. 7 indexed citations

Rosen, Mark D., Craig R. Woods, Steven D. Goldberg, et al.. (2009). Discovery of the first known small-molecule inhibitors of heme-regulated eukaryotic initiation factor 2α (HRI) kinase. Bioorganic & Medicinal Chemistry Letters. 19(23). 6548–6551. 34 indexed citations

Rosen, Mark D., Michael D. Hack, Brett D. Allison, et al.. (2008). Discovery of potent cholecystokinin-2 receptor antagonists: Elucidation of key pharmacophore elements by X-ray crystallographic and NMR conformational analysis. Bioorganic & Medicinal Chemistry. 16(7). 3917–3925. 7 indexed citations

10.

Lebsack, Alec D., Michael D. Hack, Wei Xiao, et al.. (2008). Identification and synthesis of 2,7-diamino-thiazolo[5,4-d]pyrimidine derivatives as TRPV1 antagonists. Bioorganic & Medicinal Chemistry Letters. 19(1). 40–46. 18 indexed citations

11.

Kuei, Chester, Steven W. Sutton, Pascal Bonaventure, et al.. (2007). R3(BΔ23–27)R/I5 Chimeric Peptide, a Selective Antagonist for GPCR135 and GPCR142 over Relaxin Receptor LGR7. Journal of Biological Chemistry. 282(35). 25425–25435. 116 indexed citations

12.

Woods, Craig R., Michael D. Hack, Brett D. Allison, et al.. (2007). Synthesis and solid-phase purification of anthranilic sulfonamides as CCK-2 ligands. Bioorganic & Medicinal Chemistry Letters. 17(24). 6905–6909. 8 indexed citations

13.

Gomez, Laurent, Michael D. Hack, Jiejun Wu, et al.. (2007). Novel pyrazole derivatives as potent inhibitors of type II topoisomerases. Part 1: Synthesis and preliminary SAR analysis. Bioorganic & Medicinal Chemistry Letters. 17(10). 2723–2727. 73 indexed citations

14.

Wiener, John J. M., Laurent Gomez, Hariharan Venkatesan, et al.. (2007). Tetrahydroindazole inhibitors of bacterial type II topoisomerases. Part 2: SAR development and potency against multidrug-resistant strains. Bioorganic & Medicinal Chemistry Letters. 17(10). 2718–2722. 50 indexed citations

15.

Blevitt, Jonathan M., Frank U. Axe, Michael D. Hack, et al.. (2007). 2-Aryl benzimidazoles featuring alkyl-linked pendant alcohols and amines as inhibitors of checkpoint kinase Chk2. Bioorganic & Medicinal Chemistry Letters. 17(23). 6467–6471. 32 indexed citations

16.

Gomez, Laurent, Michael D. Hack, Kelly J. McClure, et al.. (2007). SAR studies of 1,5-diarylpyrazole-based CCK1 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 17(23). 6493–6498. 13 indexed citations

17.

Arienti, Kristen L., Daniel J. Buzard, Michael D. Hack, et al.. (2006). Identification of 2-arylbenzimidazoles as potent human histamine H4 receptor ligands. Bioorganic & Medicinal Chemistry Letters. 16(23). 6043–6048. 38 indexed citations

18.

Sehon, Clark A., Kelly J. McClure, Michael D. Hack, et al.. (2005). Pyrazole CCK1 receptor antagonists. Part 2: SAR studies by solid-phase library synthesis and determination of Free–Wilson additivity. Bioorganic & Medicinal Chemistry Letters. 16(1). 77–80. 19 indexed citations

19.

McClure, Kelly J., Michael D. Hack, Clark A. Sehon, et al.. (2005). Pyrazole CCK1 receptor antagonists. Part 1: Solution-phase library synthesis and determination of Free–Wilson additivity. Bioorganic & Medicinal Chemistry Letters. 16(1). 72–76. 20 indexed citations

20.

Topaler, Maria S., Michael D. Hack, Thomas C. Allison, et al.. (1997). Validation of trajectory surface hopping methods against accurate quantum mechanical dynamics and semiclassical analysis of electronic-to-vibrational energy transfer. The Journal of Chemical Physics. 106(21). 8699–8709. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact